Previous 10 | Next 10 |
Although Strongbridge Biopharma (SBBP) saw its Q1 net loss narrow by ~7.5% to $11.8M, shares are down 1.7% in premarket trading.For Q1, the rare diseases treatment company beat estimates for EPS but missed on revenue.Sales of neuromuscular drug KEVEYIS (dichlorphenamide) rose 25% ye...
Strongbridge Biopharma (SBBP): Q1 GAAP EPS of -$0.18 misses by $0.05.Revenue of $8.38B (+125537.2% Y/Y) beats by $8.37B.Shares -1.6% PM.Press Release For further details see: Strongbridge Biopharma EPS misses by $0.05, beats on revenue
~ Reports KEVEYIS ® (dichlorphenamide) First Quarter 2021 Revenue of $8.4 Million, a 25 Percent Increase Compared to $6.7 Million of Revenue During First Quarter of 2020 ~ ~ Reiterates Full-Year 2021 KEVEYIS ® (dichlorphenamide)...
DUBLIN, Ireland and TREVOSE, Pa., May 06, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced th...
SBBP has an approved product and a late-stage pipeline. However, Cushing's syndrome is a highly-differentiated market. Despite its positives, I'm not convinced about the long-term prospects of SBBP. For further details see: Strongbridge: Approved Drugs, Near-Term Catalys...
Strongbridge Biopharma (SBBP) rose ~21.5% in early after hours in reaction to the company announcement of a peer-reviewed publication of its results from Phase 3 SONICS study of Recorlev (levoketoconazole) in patients with Cushing’s syndrome.The manuscript titled “Levoketoc...
RECORLEV ® (levoketoconazole) Treatment Demonstrates Clinically Meaningful Improvements in Cortisol Control and Clinical Benefit in Patients with Cushing’s Syndrome and Comorbid Diabetes Mellitus DUBLIN, Ireland and TREVOSE, Pa., April 07, 2021 (GLOBE NEWSWIRE) -- ...
Strongbridge Biopharma ([[SBBP]] +5.9%) is on the rise in the morning hours after announcing the detailed results from the Phase 3 LOGICS study of Recorlev (levoketoconazole) in patients with endogenous Cushing’s syndrome.Data disclosed in a poster session at the ongoing Annu...
Some Of The Best Penny Stocks To Watch Early This Week This week has started stronger than the last & we have plenty of trending penny stocks to watch as a result. Last week the markets sold off, with tech continuing its move lower. What’s more, over the weekend, new virus da...
Support.com (SPRT) +271% as Greenidge Generation Holdings to go public via merger with the company.Seneca Biopharma (SNCA) +30%.Cemtrex (CETX) +21%.Marker Therapeutics (MRKR) +19%.Acer Therapeutics (ACER) +19%.Kansas City Southern (KSU) +17% as Canadian Pacific to buy the company fo...
News, Short Squeeze, Breakout and More Instantly...
Strongbridge Biopharma plc Company Name:
SBBP Stock Symbol:
NASDAQ Market:
Strongbridge Biopharma plc Website:
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the "Court") has approved the previously announced proposed a...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “ Company ” or “ Strongbridge ”) today announced that the High Court of Ireland (the “ Court ”) has set the dat...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “ Company ” or “ Strongbridge ”) today announced that its shareholders have voted to approve the previously announced proposed ac...